Nifoxipam

Nifoxipam
Systematic (IUPAC) name
5-(2-fluorophenyl)-3-hydroxy-7-nitro-1,3-dihydro-1,4-benzodiazepin-2-one
Legal status
Legal status
Identifiers
CAS Number 74723-10-7
PubChem CID 3058221
ChemSpider 2319383
Chemical data
Formula C15H10FN3O4
Molar mass 315.256 g/mol

Nifoxipam (3-hydroxydesmethylflunitrazepam, DP 370) is a benzodiazepine that is a minor metabolite of flunitrazepam and has been sold online as a designer drug.[1][2][3][4][5][6][7][8]

Nifoxipam produces strong tranquillising and sleep-prolonging effects and has much lower toxicity compared to lormetazepam and flunitrazepam in mice.[1]

See also

References

  1. 1 2 Klaus Dr. Posselt, Hans Heinrich Prof. Dr. Med. Wagener, Klaus Dr. Gruber (16 October 1985). "Patent EP 0158267 A2 - Pharmaceutical composition containing 5-(2-fluorophenyl)-1,3-dihydro-3-hydroxy-7-nitro- or 5-(2-fluorophenyl)-1,3-dihydro-3-hydroxy-1-methyl-7-nitro-2H-1,4-benzodiazepin-2-one and process for their preparation". Retrieved 3 August 2015.
  2. "Substance Name: 2H-1,4-Benzodiazepin-2-one, 1,3-dihydro-5-(2-fluorophenyl)-3-hydroxy-7-nitro-". TOXNET. Retrieved 3 August 2015.
  3. "Neue psychoaktive Substanzen". Gesundheit Österreich GmbH. 13 January 2015. Retrieved 3 August 2015.
  4. Tansel Kilicarslan, Robert L. Haining, Allan E. Rettie, Usanda Busto, Rachel F. Tyndale, Edward M. Sellers (April 2001). "Flunitrazepam Metabolism by Cytochrome P450s 2C19 and 3A4". Drug Metabolism and Disposition 29 (4): 460–465. PMID 11259331.
  5. Moosmann, Bjoern; King, Leslie A.; Auwärter, Volker (2015). "Designer benzodiazepines: A new challenge". World Psychiatry 14 (2): 248–248. doi:10.1002/wps.20236. ISSN 1723-8617. PMC 4471986. PMID 26043347.
  6. Kevin Flemen (August 2015). "Drug Facts - Newer Unregulated Drugs" (PDF). KFx. Retrieved 15 August 2015.
  7. "Nifoxipam". WEDINOS.
  8. Markus R. Meyer, Madeleine Pettersson Bergstrand, Anders Helander, Olof Beck (2016). "Identification of main human urinary metabolites of the designer nitrobenzodiazepines clonazolam, meclonazepam, and nifoxipam by nano-liquid chromatography-high-resolution mass spectrometry for drug testing purposes". Analytical and Bioanalytical Chemistry. doi:10.1007/s00216-016-9439-6. PMID 27071765.


This article is issued from Wikipedia - version of the Sunday, April 17, 2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.